Fig. 1: Summary of plasma samples used in the study. | Nature Communications

Fig. 1: Summary of plasma samples used in the study.

From: Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer

Fig. 1

a Description of plasma samples obtained from patients with advanced breast cancer across Plasma-1 and Plasma-2 cohorts. b Description of samples from patients with advanced HR+/HER2- breast cancer treated with endocrine therapy and a CDK4/6 inhibitor (CDK-Validation-1 and CDK-Validation-1 cohorts). TF tumor fraction.

Back to article page